# Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd, Jinhua, China – FDA Inspections

Source: https://www.keypedia.com/companies/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/0a04fd37-1d04-4aa6-96f6-a25e6b2c756b

> Inspection records and compliance data for Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd in Jinhua. 3 FDA inspections on record, last inspected October 24, 2025.

---

## Details

- Name: Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd
- FEI Number: 3008259952
- Address Line 1: 519 Jiang South Rd, Hengdianzhen Dongyang
- City: Jinhua
- Country Name: China
- Address: 519 Jiang South Rd, Hengdianzhen Dongyang, Jinhua, China
- Country: China

## Related Documents

- [FDA Inspection 1293216 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2025-10-24](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/eb40ccae-71b1-45da-a8f9-251bc5918e4f) — source: FDA, date: October 24, 2025
- FDA Inspection 1293216 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2025-10-24 — source: FDA, date: October 24, 2025
- FDA Inspection 1293216 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2025-10-24 — classification: No Action Indicated (NAI), source: FDA, date: October 24, 2025
- FDA Inspection 1293216 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2025-10-24 — classification: No Action Indicated (NAI), source: FDA, date: October 24, 2025
- FDA Inspection 1209415 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2023-06-02 — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2023
- FDA Inspection 1209415 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2023-06-02 — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2023
- FDA Inspection 872735 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - 2014-03-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2014

## Related Companies

- [Suanfarma Italia S.p.A.](https://www.keypedia.com/companies/suanfarma-italia-spa/389e5bad-d737-4ee1-9a28-c04146f7c994)
- [Shandong Xinhua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-co-ltd/acea3619-5739-4a9f-a4b2-82e0207194b3)
- [Norchim](https://www.keypedia.com/companies/norchim/b562ff1d-91f8-477f-b23e-7d4bcb5aa618)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/5f1fa8da-b68a-4d31-bbfa-2aba62e8a4d1)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [PolyPeptide Laboratories, Inc.](https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Minakem Beuvry Production SAS](https://www.keypedia.com/companies/minakem-beuvry-production-sas/8fb2d8e7-cb14-4356-8902-bb679852c669)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)
- [Dottikon Exclusive Synthesis AG](https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074)
- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)